Is Ready‐To‐Use AbobotulinumtoxinA More Effective Than OnabotulinumtoxinA for Glabellar Lines? A Randomized, Controlled, Triple‐Blinded Clinical Trial
The RTUaboBoNT-A demonstrated similar efficacy, durability, and safety profile to OnaBoNT-A for the treatment of glabellar lines. With minor differences in satisfaction and injection disconfort.
Authors
- Alfonso Sánchez‐Ayala (ORCID: https://orcid.org/0000-0003-3426-0997)
- Lígia Figueiredo Valesan (ORCID: https://orcid.org/0000-0003-0783-7084)
- Ana Claudia Carbone (ORCID: https://orcid.org/0009-0006-2275-0437)
- Giancarlo De la Torre Canales
- Jacqueline Rosa Gonçalves
- Mariana Barbosa Câmara‐Souza
- Ana Claudia Laureano Navarro Shishido
Institutions
- Karolinska University Hospital (SE)
- Karolinska Institutet (SE)
- Escola Superior de Saúde Egas Moniz (PT)
- Universidade Federal de Santa Catarina (BR)
- Faculdade São Leopoldo Mandic (BR)
- Universidade Estadual de Ponta Grossa (BR)
Publication Details
- Journal
- Journal of Cosmetic Dermatology
- Published
- 2026-03-26
- DOI
- https://doi.org/10.1111/jocd.70816
- Primary Topic
- Botulinum Toxin and Related Neurological Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00